Taiwan · Delayed Price · Currency is TWD Meribank Biotech Statistics
Total Valuation
TPEX:4724 has a market cap or net worth of TWD 894.50 million. The enterprise value is 1.79 billion.
| Market Cap | 894.50M |
| Enterprise Value | 1.79B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4724 has 95.98 million shares outstanding. The number of shares has increased by 9.70% in one year.
| Current Share Class | 95.98M |
| Shares Outstanding | 95.98M |
| Shares Change (YoY) | +9.70% |
| Shares Change (QoQ) | +7.62% |
| Owned by Insiders (%) | 37.44% |
| Owned by Institutions (%) | n/a |
| Float | 45.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 14.31 |
| P/OCF Ratio | 12.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.61, with an EV/FCF ratio of 28.66.
| EV / Earnings | n/a |
| EV / Sales | 4.39 |
| EV / EBITDA | 34.61 |
| EV / EBIT | n/a |
| EV / FCF | 28.66 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.91.
| Current Ratio | 1.70 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 18.93 |
| Debt / FCF | 17.24 |
| Interest Coverage | -4.44 |
Financial Efficiency
Return on equity (ROE) is -11.33% and return on invested capital (ROIC) is -2.86%.
| Return on Equity (ROE) | -11.33% |
| Return on Assets (ROA) | -2.36% |
| Return on Invested Capital (ROIC) | -2.86% |
| Return on Capital Employed (ROCE) | -4.22% |
| Weighted Average Cost of Capital (WACC) | 3.96% |
| Revenue Per Employee | 2.88M |
| Profits Per Employee | -951,232 |
| Employee Count | 142 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 34.69 |
Taxes
| Income Tax | -6.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.29% in the last 52 weeks. The beta is 0.43, so TPEX:4724's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -46.29% |
| 50-Day Moving Average | 9.56 |
| 200-Day Moving Average | 13.47 |
| Relative Strength Index (RSI) | 58.91 |
| Average Volume (20 Days) | 62,621 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4724 had revenue of TWD 408.48 million and -135.08 million in losses. Loss per share was -1.41.
| Revenue | 408.48M |
| Gross Profit | 142.93M |
| Operating Income | -105.68M |
| Pretax Income | -142.74M |
| Net Income | -135.08M |
| EBITDA | -38.04M |
| EBIT | -105.68M |
| Loss Per Share | -1.41 |
Balance Sheet
The company has 191.32 million in cash and 1.08 billion in debt, with a net cash position of -886.26 million or -9.23 per share.
| Cash & Cash Equivalents | 191.32M |
| Total Debt | 1.08B |
| Net Cash | -886.26M |
| Net Cash Per Share | -9.23 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 12.32 |
| Working Capital | 176.13M |
Cash Flow
In the last 12 months, operating cash flow was 70.04 million and capital expenditures -7.53 million, giving a free cash flow of 62.51 million.
| Operating Cash Flow | 70.04M |
| Capital Expenditures | -7.53M |
| Depreciation & Amortization | 67.64M |
| Net Borrowing | -83.58M |
| Free Cash Flow | 62.51M |
| FCF Per Share | 0.65 |
Margins
Gross margin is 34.99%, with operating and profit margins of -25.87% and -33.07%.
| Gross Margin | 34.99% |
| Operating Margin | -25.87% |
| Pretax Margin | -34.94% |
| Profit Margin | -33.07% |
| EBITDA Margin | -9.31% |
| EBIT Margin | -25.87% |
| FCF Margin | 15.30% |
Dividends & Yields
TPEX:4724 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.70% |
| Shareholder Yield | -9.70% |
| Earnings Yield | -15.10% |
| FCF Yield | 6.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |